Cargando…
Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
BACKGROUND: Hodgkin's lymphoma has high rates of cure, but in 15% to 20% of general patients and between 35% and 40% of those in advanced stages, the disease will progress or will relapse after initial treatment. For this group, hematopoietic stem cell transplantation is considered one option o...
Autores principales: | Cortez, Afonso José Pereira, Dulley, Frederico Luiz, Saboya, Rosaura, Mendrone Júnior, Alfredo, Amigo Filho, Ulisses, Coracin, Fabio Luiz, Buccheri, Valéria, Linardi, Camila da Cruz Gouveia, Ruiz, Milton Artur, Chamone, Dalton de Alencar Fischer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Hematologia e Hemoterapia
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521428/ https://www.ncbi.nlm.nih.gov/pubmed/23284236 http://dx.doi.org/10.5581/1516-8484.20110007 |
Ejemplares similares
-
Busulfan and melphalan as conditioning regimen for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia in first complete remission
por: Bueno, Nadjanara Dorna, et al.
Publicado: (2011) -
Analysis of the feasibility of early hospital discharge after autologous hematopoietic stem cell transplantation and the implications to nursing care
por: Barban, Alessandra, et al.
Publicado: (2014) -
Oral health as a predictive factor for oral mucositis
por: Coracin, Fabio Luiz, et al.
Publicado: (2013) -
Prevalence of non-Hodgkin lymphomas in São Paulo, Brazil
por: Gouveia, Gisele Rodrigues, et al.
Publicado: (2011) -
The Use of Imatinib Mesylate as a Lifesaving Treatment of Chronic Myeloid Leukemia Relapse after Bone Marrow Transplantation
por: Conchon, Monika, et al.
Publicado: (2009)